MedTrace Logo

Innate Immune Response in COPD

NCT02637219 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2015-12-22

No results posted yet for this study

Summary

The purpose of this study is to determine whether the response of the immune system to bacterial components differs between patients with severe COPD compared to those with less severe COPD.

Conditions

  • Pulmonary Disease, Chronic Obstructive
  • Immunity, Innate
  • Inflammation
  • Bronchitis, Chronic
  • Toll-Like Receptors

Sponsors & Collaborators

Principal Investigators

  • Vincent Fan, MD MPH · VA Puget Sound Health Care System

Eligibility

Min Age
50 Years
Max Age
89 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2008-01-31
Completion
2008-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02637219 on ClinicalTrials.gov